NRXS Competitors & Alternatives
Compare Neuraxis, Inc. with similar stocks in the same industry
Biotechnology
NRXS
Main Stock$7.40
Tradestie Score
38
Market Cap
$30.70M
Revenue Growth
1.2%
Analyst Upside
+48.6%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.49
|
$158.43M | - | 58 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 48 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 49 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.15
|
$67.94M | - | 58 | Compare |
|
XLO
Xilio Therapeutics, Inc. Common Stock
|
$7.57
|
$43.15M | - | 35 | Compare |
|
ACXP
Acurx Pharmaceuticals, Inc. Common Stock
|
$1.14
|
$7.29M | - | 52 | Compare |
More NRXS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 3845)
223 stocks in this industry